NANOG and teratoma: Previous studies have shown that AFMSCs obtained from early and second-trimester AF can express various ESCs markers such as OCT-4, SOX2, NANOG, SSEA4, and TRA1-81, which may raise the concern of teratoma formation post-transplantation [1].